The Xolair Pregnancy Registry (EXPECT): Perinatal outcomes among pregnant women with asthma treated with omalizumab (Xolair) compared against those of a cohort of pregnant women with moderate-to-severe asthma

Autor: Namazy, Jennifer A., Blais, Lucie, Andrews, Elizabeth B., Scheuerle, Angela E., Cabana, Michael D., Thorp, John M., Veith, Joachim H., Umetsu, Dale T., Sun, Diana, Kaufman, Derrick G., Covington, Deborah L., Mukhopadhyay, Santanu, Fogel, Robert B., Lopez-Leon, Sandra, Spain, Vic
Zdroj: In The Journal of Allergy and Clinical Immunology February 2019 143(2) Supplement:AB103-AB103
Databáze: ScienceDirect